Palantir wins a three-year deal worth $44.4M with the FDA to use Palantir software to power drug reviews and inspections, including possible COVID-19 treatments (Lizette Chapman/Bloomberg)

on December 08, 2020

Lizette Chapman / Bloomberg: Palantir wins a three-year deal worth $44.4M with the FDA to use Palantir software to power drug reviews and inspections, including possible COVID-19 treatments — Palantir Technologies Inc. won a deal with the U.S. Food and Drug Administration to help power drug reviews and inspections …
http://dlvr.it/RnBYrz

ToyerToys

Search This Blog

VR gaming was one of my favourite hobbies of 2024 and it's because I've noticed myself using it as a meditation exercise

Palantir wins a three-year deal worth $44.4M with the FDA to use Palantir software to power drug reviews and inspections, including possible COVID-19 treatments (Lizette Chapman/Bloomberg)

Comments

Post a Comment